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Over the last 30 years the combination of both a sedentary lifestyle and excessive food availability has led to a significant increase
in the prevalence of obesity and aggravation of rates of metabolic syndrome and type 2 diabetes mellitus (T2DM). Several lines
of scientific evidence have been demonstrating that a low level of physical activity and decreased daily energy expenditure leads
to the accumulation of visceral fat and, consequently, the activation of the oxidative stress/inflammation cascade, which underlies
the development of insulin resistant T2DM and evolution of micro, and macrovascular complications. This paper focuses on the
pathophysiological pathways associated with the involvement of oxidative stress and inflammation in the development of T2DM
and the impact of regular physical exercise (training) as a natural antioxidant and anti-inflammatory strategy to prevent evolution
of T2DM and its serious complications.
1. Introduction
Oxidation is viewed in general as a chemical process whereby
electrons are removed from molecules, generating highly
reactive free radicals, which include reactive oxygen species
(ROS), such as superoxide and hydroperoxyl, and reactive
nitrogen species (RNS) [1]. Reactive species arise as natural
byproducts of aerobic metabolism at rest and play a role in
several signalling cascades of distinct physiological processes,
including phagocytosis, vasorelaxation, and neutrophil func-
tion [2, 3]. Excessive levels of ROS or reduction of the antiox-
idant defenses, such as superoxide dismutases (SODs), heme
oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase-1
(NQO-1), catalase or thioredoxin, causes oxidative stress,
as has been repeatedly described for a number of various
diseases, including type 2 diabetes mellitus (T2DM) [4–12].
Recent work has indicated that chronic inflammation,
together with oxidative stress, is an important pathophysi-
ological factor in the development of T2DM, in particular
through the eﬀects of proinflammatory cytokines, such as C-
reactive protein (CRP), tumor necrosis factor alpha (TNF-
α), interleukin (IL)-6 and IL-1β, among others [8, 13,
14]. On the contrary, anti-inflammatory cytokines, such as
adiponectin and IL-10, seem to be protective against those
pathological conditions, namely, by inhibiting TNF-α action
on adhesion of endothelial cell, reducing nuclear factor (NF)-
κB activation, and delaying macrophage foam-cell develop-
ment [15–17]. Inflammatory cytokines are potent stimula-
tors for the production of reactive species by macrophages
and monocytes, thus inducing oxidative stress [18]. Addi-
tionally, and simultaneously, an increase in oxidative stress
derived-inflammation has been hypothesized to be a major
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mechanism in the pathogenesis and progression of T2DM
[19].
Regular exercise (with or without caloric restriction) has
been increasingly viewed as an eﬀective therapeutic strategy
for the management of T2DM [20]. Indeed, aerobic and
regular exercise improves metabolic status and insulin sen-
sitivity, reducing the risk of cardiovascular disease [21]. Data
from the literature suggest that acute exercise increases oxi-
dative stress, in contrast to chronic exercise, in which adap-
tation to the stimulus decreases oxidative stress. Therefore,
it appears that acute exercise induces the generation of ROS
whereas exercise training maintains redox homeostasis [22–
24]. Concurrently, while a single bout of acute exercise is
accompanied by a proinflammatory response that in many
aspects is similar to those induced by infection and sepsis
[25, 26], regular exercise has anti-inflammatory eﬀects [27,
28]. Therefore, the objectives should be defined for each case,
in a way that does not impair or overstimulate an immune
response. Although there are clear benefits of exercise
practice in diabetic patients, a detailed comprehension of
the molecular basis underlying these helpful eﬀects remains
incomplete.
Based on the current literature, as well as on our knowl-
edge concerning the eﬀects of exercise training in an obese
animal model of T2DM, the Zucker Diabetic Fatty (ZDF)
rats, this paper will briefly review, firstly, the key pathophysi-
ological aspects of the disease, focusing on the involvement
of oxidative stress and inflammation and then the use of
regular physical exercise of moderate intensity (training)
as a strategy to improve antioxidant and anti-inflammatory
status in T2DM.
2. Oxidative Stress and Inflammation in
Type 2 Diabetes Mellitus
2.1. Oxidative Stress and T2DM. Increasing evidences link
free radicals and oxidative stress to the pathogenesis of
T2DM and development of complications [12, 29–32]. Sev-
eral studies, both in animal models of diabetes and in
diabetic patients, have shown that elevated extra- and intra-
cellular glucose concentrations result in oxidative stress and
contribute to the development and progression of diabetes
and related complications [33–37].
Major sources of oxidative stress during diabetes include
glucose autooxidation, overproduction of ROS by mito-
chondria, nonenzymatic glycation, and the polyol pathway
[38, 39]. In the latter, aldose reductase converts glucose into
sorbitol with NADPH as a coenzyme; in diabetic conditions,
increased flux through the polyol pathway enhances oxida-
tive stress due to increased consumption of NADPH by
aldose reductase. Since NADPH is required for generation
of endogenous antioxidant glutathione (GSH), reduced
NADPH availability depletes GSH, leading to greater oxida-
tive stress [40, 41] (Figure 1). Other mechanism through
which diabetes can increase oxidative stress involves electron
transport in mitochondria. It has been proposed that high
intracellular glucose levels increase the transfer of electrons
through the electron transport chain in mitochondria during
oxidative respiration, generating ROS [40, 42]. Furthermore,
changes caused by diabetes alter the redox balance and aﬀect
redox-sensitive proteins, such as protein kinase C-epsilon,
which enhances mitochondrial ROS production. Addition-
ally, advanced glycation end-products (AGEs) generated
under conditions of hyperglycemia stimulate NADPH oxi-
dase that, in turn, can induce production of ROS (Figure 1).
In a surprising development, augmentedWnt signaling stim-
ulates mitochondrial biogenesis that can lead to increased
ROS levels in mitochondria and greater oxidative damage
[43]. Increased mitochondrial ROS is harmful by several
reasons, including the damages caused on mitochondrial
components, such as DNA, membrane proteins and lipids;
opening of the mitochondrial permeability transition pore
(MPTP) [44], thus releasing proapoptotic proteins from
the mitochondria, such as cytochrome c, that stimulate cell
death. ROS generated in the mitochondrial respiratory chain
have been proposed as secondary messengers for activation
of NF-κB by TNF-α and IL-1 [42] (Figure 1). Although most
data demonstrate mitochondria ROS overproduction (first
of all superoxide) in diabetes and diabetic complications,
some studies suggested that there are other key sources
responsible for ROS overproduction (oxidative stress) in
diabetes, such as glucose-stimulated superoxide formation
catalyzed by NADPH oxidase [45, 46], or insulin (that stim-
ulate superoxide formation catalyzed by NADPH oxidase) or
even superoxide production catalyzed by xanthine oxidase
[47, 48]. Other studies have referred the role of lipoxygenases
as producers of reactive radicals during enzymatic reactions
[49, 50]. Lipoxygenase products, especially 12(S)-HETE and
15(S)-HETE, are involved in the pathogenesis of several
diseases, including diabetes, where they have proatherogenic
eﬀects and mediate the actions of growth factors and pro-
inflammatory cytokines [49, 50].
Nonmitochondrial sources of ROS also include cyclooxy-
genase (COX) enzymes, which catalyze the synthesis of
various prostaglandins. Pro-inflammatory cytokines seem to
induce COX2 expression through NADPH oxidase stimula-
tion and ROS production. Elevated levels of glucose are able
to induce endothelium-derived vasoconstrictor prostanoids
[51], suggesting a role for COX2 in diabetic vasculopathies.
Further evidence supporting a role for oxidative stress in
the induction of COX expression is the fact that expression
of COX enzymes is normalized by glycemic control [52],
and also by inhibition of oxidative phosphorylation, protein
kinase C, NF-κB [42] or by mutation of the NFκB binding
elements at the COX2 promoter site [53].
Another source of ROS is the cytochrome P450 mono-
oxygenases, a large category of enzymes involved in the
metabolism and detoxification of endogenous and exoge-
nous compounds [54]. Diabetes aﬀects the diﬀerent isoforms
of the cytochrome P450 system and seems to be responsible
for adverse hepatic events associated with T2DM [54]. For
example, there is an increased expression of CYP2E1 in
T2DM [55] and in ob/obmice andmale fatty Zucker rat [56].
Due to a low degree of coupling between enzyme turnover
and substrate binding, CYP2E1 has an unusually high capa-
city of generating free radicals, which are thought to result
in lipid peroxidation, thus contributing to liver disease,
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Figure 1: Schematic illustration of some of the key pathophysiological aspects involved in the development of T2DM, focusing on the
involvement of oxidative stress and inflammation and underlying cellular/molecular mechanisms. AGEs, advanced glycation end-products;
COXs, cyclooxygenases; CRP, C-reactive protein; GLUT, glucose transporter; GSH, endogenous antioxidant glutathione; iCAM, intracellular
adhesion molecule-1; IL-1β, interleukin 1β; IL-6, interleukin 6; JNK, Jun N-terminal kinase; p38-MAPK, mitogen-activated protein kinase;
NADPH, nicotinamide adenine dinucleotide phosphate; NF-KB, factor nuclear kappa B; NO, nitric oxide; PKC, protein kinase C; RAGE,
receptor of advanced glycation end-products; TNF-α, tumor necrosis factor alpha; vCAM, vascular cell adhesion molecule.
including nonalcoholic steatohepatitis (NASH), which is
closely associated with T2DM [57].
ROS activate a number of stress-sensitive kinases, whose
downstream eﬀects mediate insulin resistance. Therefore,
activation of these kinases upregulates and activates nuclear
factor kappa B (NFκB) and activator protein-1 (AP-1), which
subsequently (i) activate c-Jun N-terminal kinase (JNK) and
inhibit NFκB kinase-β (IKK), (ii) transcriptionally upregu-
late pro-inflammatory cytokine genes, and (iii) increase the
synthesis of acute phase reactants (Figure 1).
2.2. Inflammation in T2DM. Obesity, as a result of inactivity
and/or overeating, plays a key role in the development
of insulin resistance and pancreatic beta-cell dysfunction.
Increased triglycerides (TGs) stores, especially in visceral or
deep subcutaneous adipose tissues, lead to large adipocytes
which are resistant to insulin-evoked lipolysis suppression,
then resulting in increased release of free fatty acids (FFAs)
and glycerol. This “dyslipidaemic phenotype of diabetes,”
characterized by increased content of TGs and oxidized low
density lipoproteins (ox-LDL), together with decreased levels
of high density lipoproteins (HDL), is responsible for the
lipotoxicity profile of diabetes (Figure 1). Lipotoxicity has
been used to describe the deleterious eﬀect of tissue fat accu-
mulation on glucose metabolism and includes the notion
that increased plasma FFA/intramyocellular levels of toxic
lipid metabolites (such as long-chain fatty acyl CoAs, diacyl-
glycerol and ceramides) play a role in the pathogenesis of
muscle/liver insulin resistance [58].
Additionally, fat cells produce adipocytokines, interact-
ing with several tissues such as muscle, liver, and arterial
tissue where they exert deleterious eﬀects on metabolism and
vascular function. The adipose tissue of obese and T2DM
individuals is infiltrated by mononuclear cells and is in a
state of chronic inflammation [59]. The adipocytes and infil-
tratedmacrophages secrete proinflammatory/prothrombotic
cytokines, such as the TNF-α, interleukin-6 (IL-6), resistin,
adipsin, acylation-stimulating protein (ASP), plasminogen
activator inhibitor 1 (PAI-1) and angiotensinogen, that pro-
mote atherogenesis and cause insulin resistance. Adipocytes
also produce adiponectin, a potent insulin-sensitizing and
antiatherogenic cytokine, now included in a vast group of
substances named adipocytokines. Low adiponectin levels
have been correlated with visceral obesity and whole-body
insulin sensitivity [60]. This fat cell hormone acts as an
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insulin sensitizer, inhibiting TGs formation in liver and
stimulating fatty acid oxidation in muscle through 5′ adeno-
sine monophosphate-activated protein kinase (AMPK) and
peroxisome proliferators activated receptor alpha (PPAR-α)
[61]. Despite their apparent importance in the insulin resis-
tance syndrome, the aforementioned adipocytokines are just
examples of a family of adipocyte-derived factors that mod-
ulate insulin resistance and systemic inflammation. Besides
new adipocytokines, also certain myokines appear to aﬀect
insulin sensitivity and inflammatory responses. As such, the
list of insulin (de)sensitizing proteins and cytokines is still
far from complete. The secretion of cytokines depends not
only on the amount of adipose tissue but also of its location
visceral or intra-abdominal fat being more harmful than
subcutaneous fat. The pro-inflammatory eﬀects of cytokines
occur via signaling cascades involving NF-κB and JNKs path-
ways [62, 63]. The increase of pro-inflammatory cytokines,
associated with the dyslipidemic profile in T2DM,modulates
the function and survival of pancreatic beta-cells. Several
studies showed that exposure of beta-cells to high levels of
saturated fatty acids and lipoproteins leads to their death.
This eﬀect is accelerated by hyperglycemia, demonstrating
that lipotoxicity and glucotoxicity, in concert, determinate
beta-cell failure [64–67] (Figure 1).
Inflammation has long been considered as a major risk
factor in diabetes and associated with development and
progression of diabetic complications [68]. Hyperglycemia-
induced oxidative stress promotes inflammation through
increased endothelial cell damage, microvascular permeabil-
ity, and increased release of pro-inflammatory cytokines,
including TNF-α, IL-6, and IL-1β, ultimately leading to
decreased insulin sensitivity and evolution of diabetic com-
plications [69, 70] (Figure 1).
2.3. The Oxidative-Inflammatory Cascade in T2DM. The
above considerations direct us to consider a tight interaction
between inflammation and oxidative stress that may be
referred as the oxidative-inflammatory cascade (OIC) in
T2DM. According to Lamb and Goldstein (2008), the OIC
is a delicate balance modulated by mediators of the immune
and metabolic systems and maintained through a positive
feedback loop [1]. Within this cascade, ROS from the
immune system, adipose tissue, and mitochondria medi-
ate/activate stress-sensitive kinases, such as JNK, protein
kinase C (PKC) isoforms, mitogen-activated protein kinase
(p38-MAPK) and inhibitor of kappa B kinase (IKK-b). These
kinases activate the expression of pro-inflammatory medi-
ators, such as TNF-α, IL-6, and monocyte chemoattractant
protein-1 (MCP-1). The action of TNF-α, MCP-1, and IL-6,
locally and/or systemically, further induces the production
of ROS, thus potentiating the positive feedback loop [71]
(Figure 1).
The vascular dysfunction accompanies T2DM and
it seems to be caused by the ROS-dependent adhe-
sion molecules, such as intracellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-
1), which facilitate the attraction, adhesion, and infiltration
of white blood cells into sites of inflammation and the for-
mation of vascular dysfunction [72, 73]. The OIC-activated
kinases are mainly responsible for the development of
insulin resistance [74–76], beta cell dysfunction [77–79] and
vascular dysfunction [80–82]. Therefore, modulation of OIC
mechanisms involved in metabolic and immune processes
can improve glucose metabolism, insulin resistance, vascular
function and, consequently, delay the development of T2DM
(Figure 1).
3. Antioxidant and Anti-Inflammatory Effect of
Exercise Training in T2DM
A sedentary lifestyle is a risk factor for T2DM, with several
clinical studies illustrating a reduction of mortality and
morbidity in physically active individuals compared to
sedentary individuals [83–85]. Exercise or physical activity
may contribute to ameliorate insulin resistance by improv-
ing insulin action and vascular function (via increased
nitric oxide (NO) bioavailability) as well as by increasing
ROS-detoxification and decreasing ROS generation [86–89].
Even though the data obtained from animal studies cannot
be directly extrapolated to humans, animal models of T2DM
can oﬀer excellent opportunities to evaluate experimental
conditions and to assess tissues that cannot be tested in
humans. Therefore, experimental studies have been con-
tributing to improve the knowledge about the endocrine,
metabolic, and morphological changes underlying the
pathogenic mechanisms of the disease, as well as about the
eﬀectiveness of therapeutic options. In the following topics,
we will review the benefits of regular aerobic exercise practice
on antioxidant defenses and on inflammatory markers of
T2DM, based on the information already available in the
literature, from both clinical and experimental studies, as
well as based on our experiments using the ZDF rat as a
model of obese T2DM.
In order to avoid repeating the information throughout
the text, the physical exercise program presented in our
studies, which will be mentioned during the paper, was a
regular and moderate intensity aerobic exercise (defined as
training), consisting of 12 weeks (1 h/day, 3 times/week) of
swimming program, voluntary, for both diabetic ZDF fa/fa
rats and lean (ZDF +/+) animals, between 8 and 20 weeks of
age [90–92]. The animals were maintained under controlled
temperature (22◦C), humidity (60%), and lighting (12 h
of light) conditions, given a rodent maintenance chow (A-
04 Panlab, Barcelona, Spain) adjusted to their respective
weights (100mg/g of weight) and distilled water ad libitum.
They perform their exercise in a cylindrical tank, 120 cm
in diameter and 80 cm in height, containing water with a
controlled temperature (30–32◦C); the animals were placed
in the tank every day at the same hour (09.00–10.00 h) under
the supervision of the same person; the swimming period
was initially for 15min/d and was gradually increased such
that the rats were able to perform exercise for 60min/d,
which was achieved in 1wk; after 1 wk of this training period,
the rats were made to swim for 1 h, three times a week; at the
end of each exercise session, the animals were dried and
kept in a warm environment; the sedentary rats were kept
in the container where the swimming sessions were held for
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a period of 60min to ensure that these control rats under-
went the same amount of stress as the test animals that
performed exercise. To minimize the acute eﬀects of the
exercise, exercised animals were sacrificed 48 h after the end
of the last training session. The night before sacrifice, food
was removed from the animals cages.
3.1. Exercise Training as a Natural Antioxidant in T2DM
3.1.1. Exercise and Oxidative Stress. In order to maintain
homeostasis, cells have developed highly complex enzymatic
and nonenzymatic antioxidant systems which, working
synergistically, can protect the body against free radical-
induced damage. Enzymatic antioxidants include GLPx,
CAT, SOD, HO-1, NAD(P)H quinone oxidoreductase-1
(NQO-1), and thioredoxin [93]. Nonenzymatic antioxidants
include vitamins E and C, thiol antioxidants (glutathione,
thioredoxin), among others [94]. In brief, SOD promotes
the dismutation of the superoxide radical to form hydrogen
peroxide (H2O2) and oxygen; glutathione peroxidase (GPx)
uses GSH as a reducing equivalent to reduce H2O2, thus
generating oxidized glutathione and water; catalase converts
H2O2 to water and oxygen; GSH can remove oxygen radicals
directly and assist in the recycling of vitamins C and E;
peroxiredoxin III, which is a member of a newly identified
family of peroxidases, is localizated within the mitochondria
and seems to be a critical regulator of mitochondrial H2O2
concentrations, which promotes apoptosis in cooperation
with other mediators of apoptotic signaling [95, 96]. All of
these antioxidants are able to combine with ROS, generating
less reactive species. Since production of ROS is a result of
normal aerobic metabolism, under physiological conditions
they are eﬃciently removed by cellular antioxidant systems.
Several studies have shown that chronic exercise training
positively alters the oxidative homeostasis of cells and tissues
by decreasing the basal levels of oxidative damage and
increasing resistance to oxidative stress [97–101]. In fact,
regular exercise causes adaptations in the antioxidant capac-
ity, protecting cells against the harmful eﬀects of oxidative
stress, thus preventing cellular damage [102]. In healthy
elderly men, after habitual physical activity, an enhancement
of intrinsic antioxidant potential, and a reduction in lipid
peroxidation occurs [103]. Adaptation to oxidative stress in
trained individuals is clearly evidenced by a decrease in DNA
damage, by sustained levels of protein oxidation and by an
increment of resistance against chronic administration of
hydrogen peroxide [103]. Training is also able to alter the
metabolism of purines, reducing the availability of substrate
for xanthine oxidase (XO) in the trained muscle and plasma
content of hypoxanthine and uric acid [104]. Previous
research has shown that exercise and physical activity upreg-
ulate antioxidant defences, which is the case of SODs in the
cardiovascular systems [105, 106]. Furthermore, the “nuclear
factor erythroid 2-related factor 2 (Nrf2)” has recently been
described as an important transcription factor against oxida-
tive stress in health and during diabetes [107]. The ability
of exercise to induce ROS activates Nrf2, which increase the
expression of antioxidant enzymes, such as GPx, GST, and
HO-1. However, there are no clear evidences concerning
the putative influence of exercise training in Nrf2 signaling
[108–110]. The importance of HO-1 in the antioxidant
defense system occurs from an induction of ferritin synthesis,
which diminishes the cellular pool of free iron and also
from the enhancement of bilirubin levels, which are potent
antioxidants [111, 112].
The above-reported protection happens under condi-
tions of moderate exercise, while exhaustive exercise can
clearly be damaging. During acute or extenuating conditions,
exercise enhances the body’s hemodynamic and metabolic
responses [113]. An immediate eﬀect of exercise is the
increased maximal oxygen consumption (V˙O2 max) and
metabolic activity, due to an increase in muscle contraction
as a result of physical activity [114]. This condition leads to
an imbalance between free radicals and antioxidants, as the
increased consumption of oxygen for respiration generates
increased amounts of ROS, mainly through leakage of elec-
trons from the mitochondrial electron transport chain and
the oxidation of xantine by xantine oxidase [115]. Despite
the paradox that exhaustive exercise might induce ROS
formation, mild oxidative stress produced by regular exercise
appears to be able to reduce oxidative damage, as above
described. The adaptive response, however, does not only
depend on the degree of stress but also on preexisting condi-
tions, as well as age, of the exercising subject.
3.1.2. Exercise and Oxidative Stress in T2DM. As commented
above, in T2DM exercise decreases ROS generation, ame-
liorates insulin resistance, and improves vascular function
[116]. Our group has demonstrated in diabetic ZDF ani-
mals submitted to a 12-week swimming training protocol
(3 h/week they will perform at a metabolic rate of 2-3 METs
with a V˙O2 ranging from 46 to 63mL·min−1·kg which
means a moderate intensity exercise ∼45–65% of V˙O2 max)
an amelioration of insulin resistance and diabetic dys-
metabolism. A decrease in systolic and mean blood pressure
and in heart rate, alongside a diminishment of diﬀerential
pressure, was also observed. The reduction of blood pressure
suggests an improvement of vascular arterial compliance,
with reduction in cardiac work and left ventricular hypertro-
phy amelioration [92, 117, 118]. The regular exercise was able
to prevent serum oxidative stress, viewed by the reduction
of lipid peroxidation, evaluated by malondialdehyde (MDA)
levels, and by the increment of serum total antioxidant
status (TAS) and SOD activity (Figures 2(a) and 2(b)), thus
reinforcing the antioxidant action of training. Furthermore,
the reduction of serum 3-nitrotyrosine (3-NT) levels in the
trained diabetic rats suggests a decrease in peroxynitrite con-
tents (Figure 2(c)). Our results were in agreement with others
that have reported increased NO production in subjects who
practiced chronic exercise, coincident with decrease in blood
pressure and platelet activation [119]. Most of the clinical
and experimental studies have reported beneficial eﬀects
of regular physical activity in increasing NO bioavailability
and in reducing oxidative stress [120–122]. Physical activity
increases eNOS expression and/or eNOS Ser phosphoryla-
tion [123], leading to a reduction of ROS generation, as well
as to a beneficial influence on gene expression of antioxidant
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Figure 2: Evolution of serumMDA (a), SOD (b), uric acid (c), and 3-NT (d) levels between the initial time (8 weeks old) and the final time
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enzymes, which promotes protective adaptations [124]. The
upregulation of antioxidant defenses in animal models of
T2DM was also observed by Nishida et al. [104], which
also reported increased Cu/Zn-SOD protein production as
a results of low-intensity exercise, in contrast with increased
Mn-SOD after moderate intensity exercise [104]. Neverthe-
less, additional work is needed to assess the importance and
physiological roles of this preferential upregulation in SODs
by exercise in diabetes.
Although antioxidant properties have been attributed to
uric acid, high levels of uric acid are strongly associated
with the development of hypertension, visceral obesity,
insulin resistance, dyslipidaemia, T2DM, kidney disease, and
cardiovascular events [125, 126]. Several studies suggest that,
under certain concentrations, uric acid might have antiox-
idant activity, preventing lipid peroxidation; nevertheless,
its association with chronic disease highlights the uric acid
oxidant-antioxidant paradox [127]. Ideally, exercise training
should be able to reduce pro-inflammatory levels of uric
acid to antioxidant and protective levels. The results of de
Lemos et al. [91] in ZDF rats submitted to 12 weeks of
swimming training showed a decreased serum uric acid, to
levels near those of the control rats (Figure 2(d)). Studies
from other authors have reported that a six-month moderate
intensity (50–70%HRmax) aerobic exercise is able to decrease
lipid peroxidation, as well as to increase GSH and catalase
activity in T2DM and obese individuals [128, 129]. A similar
study in obese individuals reported attenuation in exercise-
induced lipid peroxidation following 24 weeks of a moderate
intensity resistance training [130]. More recently, Oliveira
et al. [131] compared the eﬀects of 12 weeks training
with 3 diﬀerent types of exercise (aerobic training, strength
training and combined training) on T2DM male and female
human subjects, demonstrating that the aerobic training
program provided important upregulation in antioxidant
enzymes and increased NO bioavailability, which may help
in minimizing oxidative stress and the development of the
chronic complications of diabetes.
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3.2. Exercise Training as a Natural Anti-Inflammatory in T2DM
3.2.1. Exercise and Inflammation. The eﬀects of regular or
chronic exercise on basal levels of inflammatory mark-
ers have been used to recommend exercise as an anti-
inflammatory therapy. According to Kasapis and Thompson,
a single session of exercise triggers an increase in pro-
inflammatory cytokines release, associated with leukocytosis
and increased plasma concentration of CRP [132]. This pro-
inflammatory response to acute exercise is accompanied by
a sudden increase in oxidative stress, followed by adap-
tive mechanisms against inflammation [133]. Moreover, a
longitudinal study showed that regular training induces a
reduction in CRP levels, suggesting an inflammatory action,
visible in several conditions, including T2DM, insulin resis-
tance, and other cardiovascular/cardiometabolic diseases.
Regular exercise is associated with decreased contents of
CRP, IL-6, and TNF-α and, simultaneously, increase of anti-
inflammatory substances, such as IL-4 and IL-10 [108],
reinforcing the anti-inflammatory nature of exercise [134,
135].
Cytokines are released not only from mononuclear cells
but also from muscle cells. Starkie et al. showed that
physical exercise directly inhibits endotoxin-induced TNF-α
production in humans, most likely through IL-6 release from
exercising muscle [136]. Typically, IL-6 is the first cytokine
present in circulation after exercise practice, followed by an
increase in IL-1ra and IL-10 [137]. The ubiquitous role of
IL-6 and the hypothesis of an exercise-induced anti-
inflammatory IL-6 release were recently reviewed [138, 139].
Therefore, IL-6, a multifactorial cytokine, regulates cellular
and humoral responses and plays a pivotal role in inflamma-
tion, being associated with several pathological conditions,
including T2DM, and thus emerging as an independent early
predictor for T2DM and as a marker of low-grade inflam-
mation [138, 139]. However, what is even more interesting
concerning IL-6, as Fisman and Tenenbaum [138] com-
mented, are the putative beneficial eﬀects played as an
anti-inflammatory factor, which is particularly evident in
insulin sensitivity during exercise [138]. Therefore, a marked
increase in circulating levels of IL-6 after exercise without
muscle damage has been a remarkably consistent finding.
The magnitude by which plasma IL-6 increases is related to
exercise duration, intensity of eﬀort, muscle mass involved
in the mechanical work and endurance capacity [140]. IL-6
has been indicated as the strongest candidate for the humoral
factor released after exercise, working in a hormone-like
fashion, in which it is released by the muscle, now viewed
as an endocrine organ, for influencing other organs [139].
Although this hypothesis requires further clarification, the
role of IL-6 as both the “good” and the “bad,” depending on
the circumstances, as commented by Fisman and Tenenbaum
[138], opens a new angle on the way interleukins act, and in
particular concerning the eﬀects of exercise in insulin resis-
tance and diabetes. In this anti-inflammatory environment,
IL-6 inhibits TNF-α production, as previously reported in
animals [141]. Furthermore, exercise also suppresses secre-
tion of TNF-α by pathways independent of IL-6, as shown by
the results obtained with knockout mice for IL-6 submitted
to exercise [142]. Consistent with the improvement in
inflammatory status, exercise also interferes with circulating
adiponectin levels in T2DM.
The anti-inflammatory nature of exercise training has
been associated to a reduced cardiovascular disease, par-
ticularly due the training-evoked increased expression of
antioxidant and anti-inflammatory mediators in the vascular
wall, which could directly inhibit atherosclerosis develop-
ment [143]. The available information concerning the eﬀects
of physical exercise on adiponectin levels is scarce and
divergent [144]. Several studies showed that chronic exercise
(programs of 6 weeks to 6 months) did not induce changes
in adiponectin levels [145]. Kriketos et al. also reported,
after 2-3 sessions of moderate exercise, a remarkable increase
in adiponectin levels (260%) that remained elevated for 10
weeks, without body weight modifications [146]. The sys-
tematic review performed by Simpson and Singh [144], con-
sidering literature searches in databases conducted from ten
years and including 8 randomized controlled trials, con-
cluded that exercise of varying prescription increase serum
adiponectin in 38% of the trials, demonstrating small-to-
moderate eﬀect sizes [144]. Nevertheless, the same study
showed inconsistent data in the literature for increasing
adiponectin levels after short-term exposure to robust aer-
obic or resistance training of moderate-to-high intensities,
reinforcing the need for more studies reporting reliable
findings concerning a clear relationship between changes in
adiponectin contents and exercise mode, intensity, and fre-
quency [144]. However it has been shown that muscle Adipo
R-1 is elevated in response to physical exercise [147], which
elevates metabolic signal transduction of adiponectin, then
improving oxidative metabolism. Therefore, the regulation
of these adipocytokines, including adiponectin, is likely to
contribute to the prevention of T2DM by chronic exercise.
3.2.2. Exercise and Inflammation in T2DM. The protective
eﬀect of exercise against chronic inflammation associated
diseases may, to some extent, be ascribed to an anti-
inflammatory activity. Several studies show that markers of
inflammation are reduced following longer term behavioral
changes involving reduced energy intake and increased phys-
ical activity [134]. The data mentioned herein highlighted
the idea that the beneficial eﬀect of exercise seems to be
related to its ability to decrease inflammatory cytokines
levels and/or increase anti-inflammatory ones, which might
be also true for pathological conditions, such as T2DM.
The results of the studies conducted by de Lemos et al.,
above mentioned [90, 117, 118], clearly demonstrated the
anti-inflammatory capacity of swimming exercise training in
diabetic ZDF rat. Actually, training was able to prevent the
increase of pro-inflammatory cytokines and CRP observed
in the diabetic rats. Those findings were in the line of those
of Martin-Cordero et al., which found that obese Zucker
rats, a model of metabolic syndrome, present an impairment
of pro-inflammatory cytokines (TNF-α, IL-6, IL-1beta and
interferon gamma(IFN-γ)) release by macrophages, an eﬀect
that was improved by habitual physical activity [148, 149].
de Lemos et al. [91] also found an increment of serum
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adiponectin in trained obese diabetic ZDF (fa/fa) rats to
levels near those found in the control lean rats (Figure 3(a))
[91]. Adiponectin anti-inflammatory actions have been asso-
ciated with an improvement of cardiometabolic profile,
which might be due, at least in part, to regulatory actions
on other factors, including on CRP, IL-6, and TNF-α levels
[150], which was also demonstrated in our study using the
ZDF rat submitted to swimming exercise training (Figures
3(b), 3(c), and 3(d)). Considering that the adiponectinmeas-
urement was performed 48 hours after the last training ses-
sion, the results may suggest an extension of the anti-inflam-
matory eﬀect obtained by a single bout of exercise.
Pancreatic islets from type 2 diabetic patients present
amyloid deposits, fibrosis, and increased cell death, which are
associated with the inflammatory response [151]. T2DM is
also characterized by hyperglycemia, dyslipidemia, increased
circulating inflammatory factors and cellular stress, which
are critical in precipitating islet inflammation in vivo. Chro-
nic exposure of beta-cell to these mediators induces excessive
production of ROS and activation of caspases, which inhibit
insulin secretion and promote apoptosis of pancreatic beta-
cells [152]. The impact of islet-derived inflammatory factors
and islet inflammation on beta-cell function and mass may
be either beneficial or deleterious. Therefore, depending on
their roles in regulating pancreatic beta-cell function, some
cytokines are protective while others can be detrimental.
Actually, chronic exposure of islets to IL-1β, IFN-γ, TNF-α,
and resistin inhibits insulin secretion and induces beta-cells
apoptosis [153]. Other cytokines, such as adiponectin and
visfatin, exert protective eﬀects on pancreatic beta-cell func-
tion. In addition to circulating cytokines, islets also produce
a variety of cytokines in response to physiologic and patho-
logic stimuli, and these locally-produced cytokines play
important roles in regulation of pancreatic beta-cell function
as well [153]. To maintain the normal pancreatic beta-cell
function, the deleterious and protective cytokines need to
be balanced. The abnormal control of cytokine profile in
islets and in plasma is associated with pancreatic beta-cell
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dysfunction and T2DM [12]. All those emerging evidences
reinforce the paradigm that islet inflammation is involved
in the regulation of beta-cell function and survival in
T2DM. Few studies have previously reported the putative
beneficial eﬀects of exercise training on pancreas, per se.
Studies in Otsuka Long Evans Tokushima Fatty (OLETF),
Goto-Kakizaki (GK), Zucker fatty (ZF), and ZDF rats have
shown improvements in whole-body insulin sensitivity and
preservation of beta-cell mass after exercise training [154,
155]. Insulin sensitivity improvements by exercise may
confer an indirect beneficial eﬀect on beta-cells by decreasing
insulin demand and minimizing beta-cell exhaustion, at the
same time ameliorating hyperglycemia-mediated loss in
beta-cell function [156]; however, a direct eﬀect on pancre-
atic function could not be excluded. Although almost every
study has demonstrated beta-cell mass preservation with
exercise training, none of them focused on inflammation.
The recognition that islet inflammation is a key factor in
TD2M pathogenesis has highlighted the concern regarding
the protection of pancreatic islets and endocrine function.
Therefore, restoring the normal cytokine profile in endocrine
pancreas and plasma may hold great promise for more
eﬃcient beta-cell dysfunction treatment and T2DMmanage-
ment. de Lemos et al. [92] has demonstrated, using the ZDF
rat as animal model of obese T2DM, that exercise training
was able to prevent accumulation of pro-inflammatory cyto-
kines (IL-6 and TNF-α) on endocrine pancreas. A decrease in
pancreas immunostaining of both cytokines was observed,
suggesting a protective eﬀect of regular physical exercise
against local inflammation.
4. Conclusions and Perspectives
Type 2 diabetes, cardiovascular diseases, colon cancer, breast
cancer, and dementia constitute a cluster of diseases that
defines “a diseasome of physical inactivity” [157], thus
being of crucial importance to understand the mechanisms
underlying the deleterious eﬀects of physical inactivity and
the beneficial actions of exercise training.
Oxidative stress, as well as inflammation, plays a critical
role in the pathogenesis and progression of diabetes and
diabetic-associated morbility. There are multiple sources
of ROS production in diabetes, including those of mito-
chondrial and nonmitochondrial origins. Low-grade chronic
inflammation is characterized by augmented systemic levels
of some cytokines and CRP. The increased production of
ROS and a concomitant decline of antioxidant defensemech-
anisms lead to the activation of adipose tissue andmitochon-
dria mediate/activate stress-sensitive kinases. These kinases
activate the expression of pro-inflammatory mediators that
further induce the production of ROS and potentiate the
positive feedback loop.
Emerging evidence suggests that exercise training acti-
vates the expression of cellular antioxidant systems, but is
also able to produce ROS, which are by no means detrimen-
tal. Instead, they are required for normal force production
in skeletal muscle, for the development of training-induced
adaptation in endurance performance, as well as for the
induction of endogenous defense systems [158–160]. Regular
exercise is associated with lower levels of CRP, IL-6, and TNF-
α and, simultaneously, with increases in anti-inflammatory
substances, such as adiponectin, IL-4 and IL-10. Therefore,
regular and moderate exercise training can have antioxidant
and anti-inflammatory systemic protective eﬀects in type 2
diabetes (Figure 4). The health-beneficial eﬀects of exercise-
induced myokines and heat shock protein are also gaining
increased recognition.
Considering the data now reviewed, the evidences of ben-
eficial eﬀects of regular exercise may contribute to a growing
awareness of potential risks by sedentary populations and
public authorities and to a reinforcement of exercise pre-
scription as adjuvant to drug therapy for treatment/atten-
uation of T2DM and its serious complications. However,
further research is required to better understand the eﬀects
10 Oxidative Medicine and Cellular Longevity
of exercise on inflammatory pathways and on the oxidative
stress cascade. Furthermore, it will also be pivotal the proper
establishment of type, duration, and intensity of training
recommended in order to maximize the benefits of exercise
training for the diﬀerent subgroups of T2DM patients.
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